Mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapies

Dysproteinemias progress through a series of clonal evolution events in the tumor cell along with the development of a progressively more “permissive” immune tumor microenvironment (iTME). Novel multiparametric cytometry approaches, such as cytometry by time-of-flight (CyTOF) combined with novel gat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kourelis, Taxiarchis V., Villasboas, Jose C., Jessen, Erik, Dasari, Surendra, Dispenzieri, Angela, Jevremovic, Dragan, Kumar, Shaji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713712/
https://www.ncbi.nlm.nih.gov/pubmed/31462637
http://dx.doi.org/10.1038/s41408-019-0234-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713712/
https://www.ncbi.nlm.nih.gov/pubmed/31462637
http://dx.doi.org/10.1038/s41408-019-0234-4

Ejemplares similares